Melphalan Culprit or Confounder in Acute Encephalopathy during Autologous Hematopoietic Stem Cell Transplantation?
We report a case of a female patient with Durie-Salmon stage 3A/ISS stage I IgG kappa multiple myeloma (MM) who developed encephalopathy after high-dose melphalan and hematopoietic stem cell transplant (HSCT). The most common etiologies for encephalopathy such as infection, narcotic medications, met...
Saved in:
Main Authors: | Diógenes Alayón-Laguer, Melissa Alsina, Jose L. Ochoa-Bayona, Ernesto Ayala |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Case Reports in Transplantation |
Online Access: | http://dx.doi.org/10.1155/2012/942795 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells
by: Francesco Orio, et al.
Published: (2014-01-01) -
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation
by: Benjamin Beland, et al.
Published: (2025-01-01) -
The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
by: Eko A. Pangarsa, et al.
Published: (2021-01-01) -
Durable Leukemic Remission and Autologous Marrow Recovery with Random Chromosomal Abnormalities after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia
by: Hidekazu Nishikii, et al.
Published: (2019-01-01) -
Hematopoietic Stem Cell Transplantation: A Bioethical Lens
by: Arcangelo Liso, et al.
Published: (2017-01-01)